Total Synthesis and Stereochemical Revision of Burkholdac A

Abstract

A stereocontrolled total synthesis of burkholdac A was completed, leading to a revision of the reported stereochemistry.

burkholdac A - total synthesis - antitumor - stereochemical assignment

References and Notes

1 Montaser R. Hendrik L. Future Med. Chem.  2011,  3:  1475 

2 Suyama TL. Gerwick WH. McPhail KL. Bioorg. Med. Chem.  2011,  19:  6675 

3 Maier ME. Nat. Prod. Rep.  2009,  26:  1105 

4a Wang L. Xu ZS. Ye T. Org. Lett.  2011,  13:  2506 

4b Liu H. Liu Y. Xu ZS. Ye T. Chem. Commun.  2010,  46:  7486 

4c Li S. Chen Z. Xu ZS. Ye T. Chem. Commun.  2010,  46:  4773 

4d Gao XG. Liu Y. Kwong S. Xu ZS. Ye T. Org. Lett.  2010,  12:  3018 

4e Chen Z. Song L. Xu ZS. Ye T. Org. Lett.  2010,  12:  2036 

4f Jin Y. Liu YQ. Wang Z. Kwong S. Xu ZS. Ye T. Org. Lett.  2010,  12:  1100 

4g Liang S. Xu ZS. Ye T. Chem. Commun.  2010,  46:  153 

4h Chen B. Dai L. Zhang H. Tan W. Xu ZS. Ye T. Chem. Commun.  2010,  46:  574 

4i Li S. Liang S. Tan WF. Xu ZS. Ye T. Tetrahedron  2009,  65:  2695 

4j Li S. Liang S. Xu ZS. Ye T. Synlett  2008,  569 

4k Ren Q. Dai L. Zhang H. Tan W. Xu ZS. Ye T. Synlett  2008,  2379 

4l Chen Z. Ye T. New J. Chem.  2006,  30:  518 

4m Pang HW. Xu ZS. Chen ZY. Ye T. Lett. Org. Chem.  2005,  2:  699 

4n Peng YG. Pang HW. Xu ZS. Ye T. Lett. Org. Chem.  2005,  2:  703 

4o Peng YG. Pang HW. Ye T. Org. Lett.  2004,  6:  3781 

4p Xu ZS. Chen ZY. Ye T. Tetrahedron: Asymmetry  2004,  15:  355 

4q Xu ZS. Peng YG. Ye T. Org. Lett.  2003,  5:  2821 

4r Chen ZY. Deng JG. Ye T. ARKIVOC  2003,  (vii):  268 

5 Benelkebir H. Donlevy AM. Packham G. Ganesan A. Org. Lett.  2011,  13:  6334 

6 Biggins JB. Gleber CD. Brady SF. Org. Lett.  2011,  13:  1536 

7a Chen Y. Gambs C. Abe Y. Wentworth P. Janda KD. J. Org. Chem.  2003,  68:  8902 

7b Cheng YQ. Yang M. Matter AM. Appl. Environ. Microbiol.  2007,  73:  3460 

7c Narita K. Kikuchi T. Watanabe K. Takizawa T. Oguchi T. Kudo K. Matsuhara K. Abe H. Yamori T. Yoshida M. Katoh T. Chemistry  2009,  15:  11174 

7d Wang C. Wesener SR. Zhang H. Cheng YQ. Chem. Biol.  2009,  16:  585 

8 Brooks DW. Lu LDL. Masamune S. Angew. Chem., Int. Ed. Engl.  1979,  18:  72 

9 Yurek-George A. Habens F. Brimmell M. Packham G. Ganesan A. J. Am. Chem. Soc.  2004,  130:  1026 

10 Keck GE. Boden EP. J. Org. Chem.  1985,  50:  2394 

11a Nagao Y. Hagiwara Y. Kumagai T. Ochiai M. Inoue T. Hashimoto K. Fujita E. J. Org. Chem.  1986,  51:  2391 

11b White JD. Martin WHC. Lincoln C. Yang J. Org. Lett.  2007,  9:  3481 

11c Janssen D. Kalesse M. Synlett  2007,  2667 

11d Scheerer JR. Lawrence JF. Wang GC. Evans DA. J. Am. Chem. Soc.  2007,  129:  8968 

11e Smith AB. Simov V. Org. Lett.  2006,  8:  3315 

11f Paterson I. Steven A. Luckhurst CA. Org. Biomol. Chem.  2004,  2:  3026 

11g Romo D. Choi NS. Li S. Buchler I. Shi Z. Liu JO. J. Am. Chem. Soc.  2004,  126:  10582 

11h Velazquez F. Olivo HF. Curr. Org. Chem.  2002,  6:  303 

11i Sinz CJ. Rychnovsky SD. Angew. Chem. Int. Ed.  2001,  40:  3224 

11j Aiguadé J. González A. Urpí F. Vilarrasa J. Tetrahedron Lett.  1996,  37:  8949 

12a Shiina I. Kubota M. Oshiumi H. Hashizume M. J. Org. Chem.  2004,  69:  1822 

12b Shiina I. Fukui S. Sasaki A. Nat. Protoc.  2007,  2:  2312 

13

Synthesis of the Proposed Burkholdac A (1)
Compound 2 (46 mg, 0.04 mmol) was dissolved in MeOH-CH₂Cl₂ (50 mL, 1:9) and added to a vigorously stirred solution of I₂ (126 mg, 0.50 mmol) in MeOH-CH₂Cl₂ (200 mL, 1:9) at r.t. over 0.5 h. After 10 min, the reaction was quenched by addition of sat. aq solution of Na₂S₂O₃ (20 mL) and concentrated in vacuo. The residue was extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with sat. aq solution of Na₂S₂O₃ (20 mL) and brine (30 mL), dried over anhyd Na₂SO₄ and concentrated in vacuo. The residue was dissolved in pyridine (1 mL), after HF˙py (0.8 mL) was added at 0 ˚C, the reaction mixture was stirred at r.t. for 12 h. All volatiles were removed in vacuo; the residue was diluted with EtOAc (100 mL) and washed with HCl (20 mL, 1.0 M in H₂O) and brine (20 mL), dried over anhyd Na₂SO₄ and concentrated in vacuo. The residue was purified by flash chromatography (eluted with EtOAc-hexanes-MeOH = 3:1:0.3) to provide the desired compound 1 (13.4 mg, 63% yield over 2 steps) as a white amorphous solid: [α]_D ^²0 -166.5 (c 0.35, MeOH). ^¹H NMR (400 MHz, CD₃CN): δ = 7.71 (d, J = 5.4 Hz, 1 H), 7.09 (d, J = 9.8 Hz, 1 H), 7.02 (br s, 1 H), 5.90 (br s, 1 H), 5.77 (d, J = 15.5 Hz, 1 H), 5.58 (dd, J = 6.1, 2.3 Hz, 1 H), 4.74 (br s, 1 H), 3.97-3.92 (m, 1 H), 3.83 (ddd, J = 10.2, 6.5, 4.0 Hz, 1 H), 3.68 (td, J = 10.3, 3.0 Hz, 1 H), 3.40-3.22 (m, 2 H), 2.73-2.67 (m, 2 H), 2.64-2.56 (m, 3 H), 2.51-2.43 (m, 3 H), 2.40-2.26 (m, 3 H), 2.18-2.08 (m, 2 H), 2.06 (s, 3 H), 0.83 (d, J = 0.8 Hz, 3 H), 0.81 (d, J = 1.0 Hz, 3 H) ppm. ^¹³C NMR (100 MHz, CD₃CN): δ = 172.4, 171.4, 171.2, 170.8, 131.9, 131.0, 70.0, 69.6, 60.1, 54.9, 54.8, 43.7, 41.2, 41.2, 41.1, 31.4, 29.1, 28.3, 20.8, 15.6, 15.0 ppm. ESI-HRMS m/z calcd for C₂₂H₃₆N₃O₆S₃ ⁺ [M + H]⁺: 534.1761; found: 534.1757.

14

The Analytical Data of the Revised Burkholdac A ( epi- 1)
[α]_D ^²0 -54.0 (c 0.23, MeOH). ^¹H NMR (500 MHz, CD₃CN): δ = 7.51 (s, 1 H), 7.41 (d, J = 6.9 Hz, 1 H), 6.90 (d, J = 8.9 Hz, 1 H), 6.12-6.06 (m, 1 H), 5.90 (d, J = 15.5 Hz, 1 H), 5.56-5.54 (m, 1 H), 4.70 (td, J = 9.2, 3.6 Hz, 1 H), 4.47-4.43 (m, 1 H), 4.18-4.13 (m, 1 H), 3.33-3.30 (m, 1 H), 3.21 (d, J = 10.5 Hz, 1 H), 3.13 (d, J = 14.0 Hz, 1 H), 2.96 (dd, J = 13.1, 7.2 Hz, 1 H), 2.86-2.57 (m, 8 H), 2.25 (dq, J = 13.6, 6.8 Hz, 1 H), 2.10 (s, 3 H), 2.08-2.01 (m, 2 H), 0.96 (d, J = 6.8 Hz, 3 H), 0.87 (d, J = 6.8 Hz, 3 H) ppm. ^¹³C NMR (125 MHz, CD₃CN): δ = 173.0, 172.2, 171.7, 170.1, 132.4, 131.5, 71.7, 69.0, 63.2, 56.8, 56.4, 41.8, 41.1, 40.8, 33.3, 31.2, 30.6, 30.5, 21.1, 19.8, 15.2 ppm. ESI-HRMS: m/z calcd for C₂₂H₃₆N₃O₆S₃ ⁺ [M + H]⁺: 534.1761; found: 534.1760.